This compound is primarily utilized in biochemical research to study the role of dimethylarginine dimethylaminohydrolase (DDAH) enzymes. It acts as a selective inhibitor of hDDAH-1, making it valuable in investigating the regulation of nitric oxide (NO) production. Researchers use it to explore the impact of DDAH inhibition on cardiovascular and renal systems, as well as its potential role in diseases linked to impaired NO signaling, such as hypertension and atherosclerosis. Its application extends to drug discovery efforts aimed at developing therapeutic agents targeting DDAH-related pathways.